Alan F. Denenberg
Lawyers
Filters
Twitter $1.25 billion convertible senior notes offering
The Rule 144A offering involved 0% convertible notes due 2026
NightDragon Acquisition $345 million IPO
We advised the underwriters on the SPAC IPO and Nasdaq listing
Roku $1 billion at-the-market offering
The at-the-market SEC-registered offering included shares of Class A common stock
AVITA Medical $69.1 million follow-on offering
We advised the underwriters on the equity offering
SiTime $381 million follow-on offering
We advised the underwriters on the equity offering
Crowdstrike $400 million acquisition of Humio
We are advising Crowdstrike on the acquisition
Corvus Pharmaceuticals $34 million stock offering
We advised the underwriters on the equity offering
Bolt Biotherapeutics $230 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Terns Pharmaceuticals $127.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Revolution Medicines $300 million follow-on offering
We advised the underwriters in connection with the equity offering